Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $63.90M.
ENTERPRISE VALUE (EV)
$63.90M
Champions Oncology, Inc.
Market Cap
$68.77M
Enterprise Value (EV)
$63.90M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Champions Oncology, Inc. (CSBR) | $68.77M | $63.90M |
| Fortress Biotech, Inc. (FBIO)vs › | $68.43M | N/A |
| iBio, Inc. (IBIO)vs › | $71.05M | $16.86M |
| MindWalk Holdings Corp. (HYFT)vs › | $71.19M | $68.23M |
| Cingulate Inc. (CING)vs › | $66.20M | $44.09M |
| Gossamer Bio, Inc. (GOSS)vs › | $66.02M | $63.98M |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.90M | $191.53M |
| Gain Therapeutics, Inc. (GANX)vs › | $74.00M | $61.53M |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.47M | $67.33M |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A |
Market Cap
$68.77M
Total Debt
$0.00
Cash
$4.87M
Enterprise Value
$63.90M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
